Chronic Hives (Chronic Idiopathic Urticaria)

IWBCA
Feb 14
16 min read

Chronic hives, also called chronic urticaria or chronic idiopathic urticaria, are recurring outbreaks of itchy, raised skin welts that continue for more than six weeks and often come and go for many months or years. In many people, no clear external trigger is found, and the immune system itself appears to drive the reaction.

Overview

What are chronic hives (chronic idiopathic urticaria)?

Chronic hives are episodes of itchy, raised, red or skin-colored bumps or welts (wheals) that appear on the skin at least several times per week and persist for longer than six weeks. Individual wheals usually resolve within minutes to hours, but new ones continue to appear, so the person feels as if they “always” have hives.

The term “chronic idiopathic urticaria” reflects three key ideas. “Chronic” means the problem continues for weeks to months instead of resolving within a few days. “Idiopathic” means that no specific external cause, such as a food, medication, or infection, can be identified despite careful evaluation. “Urticaria” is the medical term for hives, pronounced ur-tik-CARE-ee-uh.

In a significant proportion of people, chronic hives are thought to be autoimmune in origin. The immune system mistakenly targets cells in the skin that release histamine and other chemicals, keeping them in an overactive state even when there is no allergen present.

Definitions

What are hives (urticaria) and angioedema (swelling)?

Hives and angioedema are related forms of the same underlying process. Hives are raised, itchy, sometimes burning bumps or patches on the surface of the skin. They can vary in size from small dots to large, map-like areas that merge together. Angioedema is a deep swelling of the tissues beneath the skin. It most often affects the eyelids, lips, tongue, throat, hands, feet, or genitals.

Many people with chronic hives have both patterns at different times. Hives tend to be more visible and intensely itchy, while angioedema may feel tight, painful, or hot. Swelling around the lips, tongue, or throat needs urgent medical attention if it interferes with breathing or swallowing.

Differentiation

What is the difference between hives and chronic hives?

The primary difference is the duration of the problem. Acute hives begin suddenly and usually fade within hours to days. Even if new patches appear as old ones disappear, the entire episode resolves within six weeks. Acute hives are often associated with a recent viral infection, a new medication, or an obvious trigger such as a specific food or an insect sting.

Chronic hives are defined by their duration and frequency. They appear at least twice a week and continue for more than six weeks, often much longer. Triggers are often unclear, and in many cases, none can be identified despite careful history and testing. Chronic hives may fluctuate in intensity, with some days much worse than others, but the tendency to develop wheals persists over time.

Prevalence

How common are chronic hives?

Chronic hives are less common than acute hives but still affect a noticeable minority of people. Over a lifetime, up to several out of every hundred people will experience chronic urticaria. The condition can occur at any age, including in children, but it is most common in adults and is more common in women, particularly between the ages of 30 and 50.

For many, chronic hives eventually improve or go into remission, but the course is unpredictable. Because the itching, sleep disruption, and visibility of the rash can affect daily activities and mood, treatment focuses on controlling symptoms and, when possible, identifying and addressing immune or autoimmune drivers rather than relying only on short courses of steroids.

Symptoms

What are the most common symptoms associated with chronic hives?

Chronic hives are defined by their duration and recurrence. Individual wheals usually appear quickly, itch intensely, then fade within hours, but new patches continue to appear for at least six weeks and often much longer. Symptoms can fluctuate day to day and are often worse in the evening or at night, affecting sleep and daily activities.

Recurrent Itchy Wheals: The hallmark of chronic hives is the appearance of raised, red or skin-colored welts, also called wheals, that itch, burn, or feel hot. These areas can be small spots or large, irregular patches that merge together. Each individual wheal usually fades within 24 hours, leaving the skin looking normal or slightly flushed; however, new wheals continue to appear in other locations, so symptoms appear ongoing.
Changing Size, Shape, and Location: Wheals can change rapidly in size and shape, sometimes expanding over minutes, fading, and then reappearing elsewhere. Many people notice that hives are worse at certain times of day, after specific activities, or in response to skin rubbing or scratching. The moving, shifting nature of the rash helps distinguish hives from many other skin conditions.
Associated Angioedema (Deeper Swelling): Some people with chronic hives also experience angioedema, a deeper swelling beneath the skin. This swelling often affects the eyelids, lips, tongue, throat, hands, feet, or genitals. Angioedema may feel tight or painful rather than itchy. Swelling around the tongue or throat that affects breathing or swallowing is a medical emergency and requires urgent care.
Skin Discomfort and Burning Sensations: In addition to itching, some wheals cause stinging, burning, or a feeling of heat in the skin. The discomfort can make it difficult to concentrate, rest, or wear certain fabrics. Repeated scratching may lead to broken skin, tenderness, or secondary irritation, even though hives themselves do not usually leave permanent marks.
Sleep Disturbance and Fatigue: Itching and flares that worsen at night often disrupt sleep. People with chronic hives may wake frequently to scratch, reposition, or apply cool compresses. Over time, poor sleep can lead to daytime fatigue, irritability, and difficulty with work or school, even when the rash itself looks modest.
Emotional and Quality-of-Life Impact: Visible wheals, unpredictable flares, and concern about new outbreaks can cause embarrassment, anxiety, or frustration. Some individuals limit clothing choices, social activities, or exercise because they fear triggering or exposing hives. When symptoms are frequent or severe, chronic hives can have a disproportionate impact on quality of life compared with how “simple” the rash may appear to others.

Causes

What are the most common causes of chronic hives?

In most people with chronic hives, no single external cause can be identified. The condition is often described as chronic idiopathic urticaria, which means hives that persist for more than six weeks without a clear trigger. Current evidence suggests that, in a large proportion of cases, the immune system itself plays a central role, either through autoimmunity or heightened sensitivity of skin mast cells.

Idiopathic or Unknown Triggers: For many individuals, chronic hives occur without an identifiable cause, even after careful review of medications, infections, foods, and environmental exposures. In this idiopathic group, hives may appear and disappear unpredictably. The absence of a clear trigger does not make the symptoms any less real or bothersome, but it does shift the approach to treatment, with greater emphasis on controlling the immune response rather than on avoiding specific exposures.

Autoimmune Mechanisms: A significant proportion of individuals with chronic hives exhibit autoimmune features. In these cases, the immune system produces antibodies that target either IgE or the high-affinity IgE receptor on mast cells and basophils in the skin. This autoantibody activity can keep these cells in an activated state, causing them to release histamine and other mediators even in the absence of allergens. Blood tests and specialized assays can sometimes detect these patterns, although they are not positive in every case of autoimmune disease.

Associated Autoimmune Diseases: Roughly one in five people with chronic hives also have a diagnosed autoimmune condition. Examples include celiac disease, dermatomyositis, diabetes, lupus, polymyositis, rheumatoid arthritis, autoimmune thyroid disease, and vitiligo. In some individuals, thyroid autoimmunity is especially common. The presence of an autoimmune disease does not establish that it causes the hives, but it supports the inference that the immune system is more prone to misdirected activity in these patients.
Medication-Related and Food-Related Causes: Medications and foods are less common causes of truly chronic hives than they are of acute hives, but they can still play a role. Drugs taken regularly, such as certain pain relievers, antibiotics, or blood pressure medications, may act as ongoing triggers in a minority of patients. Likewise, foods or food components that are consumed frequently may contribute in selected cases. True long-term allergic causes are uncommon, and elimination diets or medication changes should be guided by a clinician to avoid unnecessary restrictions.
Physical and Environmental Triggers: Some people develop hives when their skin is exposed to sudden temperature changes, friction, pressure, or exercise. Heat, cold, hot showers, vigorous activity, tight clothing, or pressure from straps and waistbands can all provoke wheals in susceptible individuals. In these situations, chronic hives may be part of a broader group of “physical urticarias,” where mechanical or environmental factors repeatedly trigger mast cell activation in the skin.
Infections and Chronic Inflammatory Conditions: Certain infections and chronic inflammatory conditions can be associated with persistent hives. Examples include recurrent sinus infections, H. pylori infection of the stomach, and certain viral or parasitic infections. Liver disease and systemic vasculitis can also be linked to urticarial rashes. In these settings, treating the underlying infection or inflammatory disease may reduce or eliminate hives, although the relationship is not always straightforward.
Mast Cell Activation and Histamine Release: Regardless of the underlying driver, chronic hives result from mast cells and basophils in the skin releasing histamine and related mediators. These chemicals cause blood vessels to leak fluid into the surrounding tissue, producing the raised, itchy wheals and, in deeper tissues, angioedema. Antihistamines, short courses of steroids, and in some cases immunosuppressants or biologic therapies are used to calm this process when avoidance of triggers is not possible or when no clear trigger is found.
Multifactorial Nature of Chronic Hives: For many people, chronic hives reflect a combination of immune sensitivity, possible autoimmune activity, and environmental factors rather than a single cause. The same person may notice that pressure or heat triggers hives on some days, whereas stress, infections, or hormonal shifts worsen them on other days. Understanding chronic hives as a multifactorial condition helps set realistic expectations: identifying and treating associated conditions is important, but ongoing symptom management with targeted medications often remains a core part of care.

Autoimmune Conditions Associated With Chronic Hives

Which autoimmune diseases are most commonly associated with chronic hives?

A significant subset of people with chronic hives also live with an autoimmune condition. In these cases, the immune system is already primed for misdirected activity, and the same immune dysregulation can target mast cells and skin vessels, increasing the likelihood of chronic hives and sometimes making them more difficult to control. The conditions listed below are among the most consistently associated with chronic urticaria in clinical studies.

Autoimmune Thyroid Disease: Autoimmune thyroid disease, including Hashimoto thyroiditis and Graves disease, is one of the strongest and most reproducible associations with chronic hives. Thyroid autoantibodies are found at higher rates in people with chronic urticaria than in the general population. Even when thyroid hormone levels are normal, this immune targeting of thyroid tissue suggests an overall tendency toward autoimmunity that can extend to mast cells in the skin. Treating overt thyroid dysfunction and monitoring thyroid status are important parts of evaluating chronic hives in this group.
Celiac Disease: Celiac disease is an autoimmune response to gluten that damages the small intestine, but it can also manifest in the skin. People with celiac disease appear to have a higher risk of chronic hives compared with the general population, likely because ongoing immune activation and autoantibody production increase the chance that the skin will become a target. In some cases, adherence to a strict gluten-free diet improves both intestinal symptoms and hives, although urticaria may not fully resolve in every individual.
Systemic Lupus Erythematosus (Lupus): Lupus is a systemic autoimmune disease that produces a wide variety of skin findings, including photosensitive rashes and urticarial lesions. In some people with lupus, chronic hives reflect immune complex deposition and complement activation in small skin vessels. This can overlap with urticarial vasculitis, which is a related but distinct process. When chronic hives occur in a patient with lupus, clinicians closely monitor other systemic signs, such as joint pain, renal involvement, or low complement levels, to determine whether the urticaria indicates broader disease activity.
Dermatomyositis: Dermatomyositis is an autoimmune condition characterized by muscle weakness and distinctive skin changes. Although the classic rash differs from typical hives, some individuals experience urticarial eruptions or hive-like lesions in association with dermatomyositis. These skin findings reflect an immune attack on blood vessels and connective tissue in the skin and can be part of a broader pattern of inflammation. When chronic hives occur in a person with dermatomyositis, they may indicate active disease and warrant adjustment of immunosuppressive therapy.
Polymyositis: Polymyositis is an autoimmune inflammatory myopathy that primarily affects muscle but, like other systemic autoimmune diseases, can coexist with chronic hives. The link appears to arise from shared immune pathways and circulating autoantibodies that increase mast cell reactivity. In this context, hives are typically among several immune-mediated symptoms, and management often involves systemic therapy targeting the underlying myositis, in addition to antihistamines.
Rheumatoid Arthritis: Rheumatoid arthritis is an autoimmune disease that primarily targets the joints but also has numerous extra-articular manifestations. Chronic hives may occur more frequently in individuals with rheumatoid arthritis than in the general population, reflecting underlying immune activation and elevated circulating inflammatory mediators. Some disease-modifying antirheumatic drugs and biologic therapies can improve both joint symptoms and urticaria by modulating the overall autoimmune process, whereas other medications may occasionally trigger or exacerbate hives, necessitating careful monitoring.
Type 1 Diabetes: Type 1 diabetes is an autoimmune attack on insulin-producing cells in the pancreas. People with type 1 diabetes are more likely to develop additional autoimmune conditions over time, including those associated with chronic hives. The connection between diabetes and chronic urticaria is less direct than for thyroid disease, but shared genetic risk and immune dysregulation likely contribute. In practice, the presence of type 1 diabetes prompts clinicians to be more alert for other autoimmune comorbidities when evaluating persistent hives.
Vitiligo: Vitiligo arises when the immune system targets pigment-producing cells in the skin, leading to areas of depigmentation. Individuals with vitiligo have an increased risk of other autoimmune diseases, and chronic hives occur more frequently in this group than in the general population. The coexistence of vitiligo and chronic urticaria suggests that the skin’s immune environment is altered in a way that both damages melanocytes and makes mast cells more prone to activation. Treatment focuses on managing each condition while recognizing its shared autoimmune etiology.
Celiac-Associated and Systemic Autoimmune Clustering: Many people with chronic hives and one autoimmune disease have additional autoimmune tendencies, such as autoimmune thyroid disease coexisting with celiac disease or type 1 diabetes. This clustering reflects shared genetic and immune risk factors. When chronic hives occur in individuals with known autoimmune conditions, or when hives are accompanied by unexplained fatigue, weight changes, joint symptoms, or gastrointestinal symptoms, clinicians often screen for associated diseases to ensure that broader autoimmune activity is not overlooked.

Sjögren’s Syndrome: Sjögren’s syndrome is a systemic autoimmune disease that primarily targets moisture-producing glands but also alters immune activity throughout the body. People with Sjögren’s have a higher rate of chronic spontaneous urticaria than the general population, and in some cases, chronic hives or recurrent “allergic” reactions are among the first noticeable symptoms before dry eyes and dry mouth are fully recognized. Case reports and cohort data describe chronic urticaria as an early or accompanying manifestation of Sjögren’s, with hives improving when the underlying rheumatologic disease is treated more aggressively.
Pernicious Anemia: Pernicious anemia is an autoimmune form of vitamin B12 deficiency caused by antibodies against intrinsic factor or gastric parietal cells. It frequently clusters with other autoimmune conditions, including autoimmune thyroid disease and vitiligo, and has been specifically reported in patients with autoimmune chronic spontaneous urticaria. In some individuals, chronic hives appear in the context of broader autoimmune polyglandular syndromes that include pernicious anemia, and recognition of the B12 deficiency becomes an important part of the evaluation in patients with otherwise unexplained chronic urticaria and systemic symptoms such as fatigue or neuropathy.
Autoimmune Gastritis: Autoimmune gastritis is characterized by immune-mediated damage to the stomach lining, often accompanied by pernicious anemia and other autoimmune diseases. Emerging reports highlight an association between autoimmune gastritis and chronic urticaria, including pediatric cases where autoimmune gastritis and chronic hives coexist as part of a broader autoimmune profile. In these patients, treating the gastric autoimmunity and correcting B12 deficiency can be clinically relevant, especially when hives are resistant to standard antihistamine regimens and accompanied by gastrointestinal complaints.
Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis): Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, is an immune-mediated condition that affects the gastrointestinal tract but also drives systemic inflammation and extra-intestinal manifestations. Large population studies of chronic spontaneous urticaria have found increased odds of inflammatory bowel disease compared with matched controls, suggesting a true association rather than coincidence. In some individuals, chronic hives occur alongside flares of Crohn’s disease or ulcerative colitis, reflecting shared immune pathways and cytokine profiles that affect both the gut and the skin.
Autoimmune Polyglandular Syndromes: Autoimmune polyglandular syndromes are conditions characterized by the co-occurrence of multiple endocrine and non-endocrine autoimmune diseases, such as autoimmune thyroid disease, type 1 diabetes, pernicious anemia, vitiligo, and autoimmune gastritis. Chronic spontaneous urticaria is reported more often in patients with these clustered autoimmune profiles than in the general population. In cohorts of CSU patients, a subset has two or more autoimmune diagnoses, most commonly autoimmune thyroiditis plus vitiligo, pernicious anemia, or rheumatoid arthritis, forming a polyglandular pattern. Recognizing the syndrome's context is important because chronic hives may be a visible manifestation of a broader autoimmune network that requires coordinated, system-level management.

Diagnosis and Testing

How are chronic hives diagnosed and which providers are involved in care?

Chronic hives are primarily a clinical diagnosis based on the rash's appearance, duration, and recurrence. Providers focus on confirming that the skin findings represent urticaria, screening for warning signs of other conditions, and determining whether limited, targeted testing is needed to evaluate for autoimmune disease, infection, or other triggers. Most people do not need extensive allergy panels or large batteries of lab tests.

Clinicians Who Commonly Evaluate Chronic Hives: Allergists, dermatologists, and primary care clinicians often work together to evaluate and manage chronic hives. A primary care provider may make the initial diagnosis and start treatment, then refer to an allergist or dermatologist if hives are severe, persistent, or difficult to control, or if there are signs of underlying autoimmune or systemic disease.
Clinical History and Physical Examination: Diagnosis usually begins with a detailed history and an examination of the skin. The provider asks when the hives started, how long individual wheals last, how often they appear, and whether there is associated swelling of the lips, eyelids, tongue, or throat. They also ask about medications, infections, physical triggers such as heat, cold, pressure, or exercise, and any personal or family history of autoimmune disease. During the exam, the provider looks for typical itchy, raised wheals, checks for signs of angioedema, and looks for features that might suggest vasculitis or another rash that can mimic hives.
Confirmation That Hives Are Chronic: Chronic hives are defined by symptoms that recur for at least six weeks. Individual wheals come and go within 24 hours, but new ones continue to appear. If the pattern has been present for a shorter time, the condition is considered acute urticaria. Providers often use the six-week time frame, along with symptom diaries, to decide whether the term “chronic” applies and whether evaluation for associated autoimmune disease or other conditions is warranted.
Targeted Laboratory Testing: Basic blood work may be ordered to look for clues to infection, inflammation, or autoimmune activity. This can include a complete blood count, markers of inflammation such as ESR or CRP, and metabolic panels if there is concern about liver or kidney disease. In people with symptoms or family histories that suggest autoimmunity, testing may include thyroid function and thyroid antibodies, celiac screening, or other autoimmune markers guided by the clinical picture.
Allergy Evaluation When Indicated: Allergy testing is helpful when the history suggests a specific trigger, such as foods, insect stings, or medications that consistently precede flares. Skin prick testing or blood tests for allergen-specific IgE can identify these patterns. For most people with chronic spontaneous urticaria, however, allergy tests are negative or do not change management, because symptoms are not driven by a single external allergen.
Urine Testing and Infection Screening: A urine test or targeted infection workup may be done if there are symptoms of urinary tract infection, chronic sinusitis, or gastrointestinal infection such as H. pylori. In selected cases, treating an underlying infection can help stabilize the immune system and reduce hives, so providers look for infection when the history or exam points in that direction.
Skin Biopsy in Atypical or Unclear Cases: When the appearance or behavior of the rash is not typical for urticaria, or when hives are painful, last more than 24 hours in one spot, bruise, or are accompanied by systemic symptoms such as fevers and joint pains, a small skin biopsy may be performed. A biopsy can distinguish ordinary hives from urticarial vasculitis and other inflammatory skin conditions that require different treatments.
Ongoing Assessment and Symptom Tracking: Even after an initial diagnosis is made, providers may ask patients to track symptoms, medications, and possible triggers over time. This helps identify patterns such as pressure-induced hives, cold-induced hives, or flares that correlate with infections, hormonal cycles, or stress. Follow-up visits are used to refine the diagnosis and adjust treatment if new information emerges.

Management and Treatment

How are chronic hives treated and what can help at home?

Treatment for chronic hives focuses on inhibiting mast cell activation and limiting the release of histamine and related mediators that cause itching, redness, and swelling. Care typically begins with non-sedating antihistamines and then progresses to higher doses, biologic therapy, or immunomodulators if symptoms remain troublesome. At the same time, gentle skin care and simple at-home measures can reduce discomfort and help prevent scratching and secondary irritation.

First-Line Antihistamine Therapy: Daily non-sedating antihistamines are the usual starting point for chronic hives. These medications block histamine receptors in the skin and reduce itching, redness, and the number of new wheals that appear. They are often taken every day, not only when hives are visible, because consistent receptor blockade helps stabilize symptoms over time.
Adjusted or Higher-Dose Antihistamine Regimens: If standard doses of a single antihistamine do not fully control symptoms, clinicians may increase the dose or add a second non-sedating antihistamine, provided that safety limits are not exceeded. For many people with chronic urticaria, this stepwise adjustment provides better control than occasional, on-demand dosing alone.
Biologic Therapy With Omalizumab: For people with chronic hives that remain moderate or severe despite optimized antihistamines, monthly injections of omalizumab are often considered. Omalizumab is a monoclonal antibody that binds to immunoglobulin E and reduces its ability to trigger mast cells. Many patients experience fewer and milder hives, improved sleep, and better quality of life after several months of therapy. Dosing and duration are individualized, and response is monitored at regular follow-ups.
Short Courses of Systemic Corticosteroids. Short courses of oral corticosteroids, such as prednisone, can help settle severe flares that do not respond to antihistamines. Steroids are powerful anti-inflammatory medications that quickly reduce swelling and itching. Because long-term use can cause significant side effects, they are usually reserved for brief periods to gain control during an acute worsening, not as a daily maintenance treatment.
Immunomodulators For Autoimmune or Refractory Chronic Hives: In suspected autoimmune chronic spontaneous urticaria or in cases that do not respond adequately to antihistamines and omalizumab, additional immunomodulating medications may be used. Examples include agents such as cyclosporine, which suppresses T-cell activity and mast cell activation, or hydroxychloroquine, which can help regulate immune responses in some autoimmune-associated cases. These drugs require careful monitoring because of potential side effects, and they are typically managed by specialists experienced in their use.
Treatment of Associated Conditions and Triggers: When chronic hives co-occur with autoimmune thyroid disease, celiac disease, chronic infection, or other systemic conditions, addressing these conditions can improve hives or make them easier to control. This may include treating H. pylori infection, optimizing thyroid hormone levels, managing autoimmune disease activity, or adjusting medications that may be contributing to symptoms.
At-Home Symptom Relief Measures: Gentle skin care and simple topical measures can reduce day-to-day discomfort. People often find relief with cool compresses applied to affected areas, short cool showers or baths, and over-the-counter anti-itch preparations that are appropriate for sensitive skin. Fragrance-free, hypoallergenic moisturizers can help maintain the skin barrier and reduce irritation.
Clothing and Environmental Strategies: Loose-fitting, soft fabrics reduce friction and pressure that might trigger or worsen hives. Avoiding tight waistbands, straps, and rough seams can be particularly beneficial for individuals with pressure-induced urticaria. Identifying and limiting exposure to personal triggers such as very hot showers, sudden temperature changes, or specific physical activities can also reduce flare frequency.
Long-Term Management and Follow-Up: Chronic hives can persist for months or years, but many people eventually experience remission or substantial improvement. Regular follow-up appointments allow the care team to adjust medications, review side effects, monitor for new autoimmune or systemic conditions, and look for opportunities to step down therapy when symptoms are stable. The goal is to keep hives quiet enough that they no longer dominate daily life while minimizing treatment burden and long-term risks.

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.